Clinical Trial Update: Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of alirocumab in patients with primary hypercholesterolemia on stable atorvastatin therapy; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• alirocumab (alirocumab)

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2015-09-24